Stockreport

AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference

AC Immune SA  (ACIU) 
Last ac immune sa earnings: 11/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acimmune.com/en/investors
PDF Lausanne, Switzerland, - February 6, 2018 -   AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neuro [Read more]